Albiglutide

What is Albiglutide?

Tanzeum, a weekly GLP-1 withdrawn from the market in 2018 for commercial reasons rather than safety.

Its outcomes trial, HARMONY OUTCOMES, still counts as class evidence.

Related reading: HARMONY OUTCOMES: A Win for a Withdrawn Drug

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where Albiglutide comes up on this site

Other terms under drug

• Liraglutide
• Exenatide
• Dulaglutide
• Contrave
• Qsymia
• Bupropion
• Naltrexone
• Phentermine
• Topiramate
• Pemvidutide
• Mazdutide

Where the evidence lives

• The full GLP-1 glossary (150 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers